3 stocks to watch today based on high retail investor interest


The following stocks are generating strong interest from retail investors on social media early Wednesday.

SoFi Technologies Inc (NASDAQ: SOFI): The personal finance company continues to dominate discussions on r / WallStreetBets, a Reddit investor forum known for its short presses.

SoFI began trading this month after merging with Social Capital Hedosophia Holdings V de Chamath Palihapitiya.

The company’s product line encompasses borrowing, savings and spending.

At the time of publication, SoFi has garnered 1,087 mentions on WSB, making it the most discussed name on the forum, according to quantitative data from Quiver.

In after-hours trading on Tuesday, the company’s shares rose 2.76% to $ 19.39 after closing down 2.02% at $ 18.87 in regular trading.

SoFi shares have jumped 51.7% year-to-date.

Clover Health Investment Corp. (NASDAQ: CLOV): The Tennessee-based Health Maintenance Organization (HMO) and Preferred Supplier Organization have been in the sights of retail investors since the spring of this year.

The company has a 36.6% short stake against a free float of 112.78 million, according to highshortinterest.com, a website that tracks heavily short stocks.

The Palihapitiya-backed company has been targeted by short seller Hindenburg Research, which published a report in February alleging it had misled investors.

Clover is number two on Quiver Quantitative’s trend list.

See also: Clover Health, Tesla, Wish, BlackBerry and Workhorse continue to generate strong interest from WallStreetBets

On Tuesday, Clover stock closed up 4.37% at $ 13.36 in the regular session and gained 0.75% in after-hours trading. Since the start of the year, Clover’s earnings have stood at 19.5%.

Altimmune Inc. (NASDAQ ALT): The clinical-stage biopharmaceutical company, which focuses on liver disease and intranasal vaccines, released a statement Tuesday saying its intranasally administered vaccine candidate AdCOVID elicited a “substantially weaker” immune response than already licensed vaccines for emergency use.

Altimmune has said it is stopping development of AdCOVID beyond the Phase 1 trial.

The company was number two on Stocktwits’ top ten trending feeds list at press time, behind cryptocurrency. Ethereum Classic (CRYPTO: ETC).

On Tuesday, Altimmune shares fell nearly 38.2% in after-hours trading to $ 9.83 after closing down 2.45% in the regular session at $ 15.90.

Altimmune shares gained 48.5% on a YTD basis.


Leave A Reply